Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA057245-04S1
Application #
2097998
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1992-08-01
Project End
1997-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost

  Institution

Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715

  Publications

Dragan, Y; Valdes, R; Gomez-Angelats, M et al. (2000) Selective loss of nucleoside carrier expression in rat hepatocarcinomas. Hepatology 32:239-46
O'Regan, R M; Cisneros, A; England, G M et al. (1998) Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth. J Natl Cancer Inst 90:1552-8
Dragan, Y P; Shimel, R J; Bahnub, N et al. (1998) Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats. Toxicol Sci 43:129-38
Nuwaysir, E F; Daggett, D A; Jordan, V C et al. (1996) Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen. Cancer Res 56:3704-10
Nuwaysir, E F; Dragan, Y P; Jefcoate, C R et al. (1995) Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. Cancer Res 55:1780-6
Sargent, L M; Dragan, Y P; Bahnub, N et al. (1994) Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats. Cancer Res 54:3357-60